₹ 48.01
-1.99 (-3.98%)
BSE
G
Genomic Valley Biotech
₹ 48.01
BSE
Genomic Valley Biotech EPS Summary
The latest quarterly EPS of Genomic Valley Biotech as of Q2 Sep 2026 stands at ₹-0.06. This is a 220.00% fall quarter on quarter and 700.00% fall same quarter last year. For the FY2026 the EPS of Genomic Valley Biotech stands at ₹0.10. This is a 91.45% fall compared with FY2025.
Genomic Valley Biotech EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

